Advertisement
ABBV or PFE or UNH
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ABBV’s FA Score shows that 4 FA rating(s) are green whilePFE’s FA Score has 2 green FA rating(s), and UNH’s FA Score reflects 3 green FA rating(s).
- ABBV’s FA Score: 4 green, 1 red.
- PFE’s FA Score: 2 green, 3 red.
- UNH’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ABBV’s TA Score shows that 6 TA indicator(s) are bullish while PFE’s TA Score has 5 bullish TA indicator(s), and UNH’s TA Score reflects 5 bullish TA indicator(s).
- ABBV’s TA Score: 6 bullish, 4 bearish.
- PFE’s TA Score: 5 bullish, 2 bearish.
- UNH’s TA Score: 5 bullish, 4 bearish.
Price Growth
ABBV (@Pharmaceuticals: Major) experienced а +4.37% price change this week, while PFE (@Pharmaceuticals: Major) price change was -0.53% , and UNH (@Managed Health Care) price fluctuated +5.04% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.22%. For the same industry, the average monthly price growth was +2.11%, and the average quarterly price growth was +2.84%.
The average weekly price growth across all stocks in the @Managed Health Care industry was +5.31%. For the same industry, the average monthly price growth was +15.86%, and the average quarterly price growth was +26.77%.
Reported Earning Dates
ABBV is expected to report earnings on Jul 24, 2026.
PFE is expected to report earnings on Aug 04, 2026.
UNH is expected to report earnings on Jul 10, 2026.
Industries' Descriptions
@Pharmaceuticals: Major (+0.22% weekly)The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
@Managed Health Care (+5.31% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
| ABBV | PFE | UNH | |
| Capitalization | 401B | 146B | 363B |
| EBITDA | 17.6B | 17.2B | 22.8B |
| Gain YTD | 1.080 | 8.085 | 21.952 |
| P/E Ratio | 111.39 | 19.88 | 30.08 |
| Revenue | 61.2B | 63.3B | 450B |
| Total Cash | N/A | 13.1B | 31.2B |
| Total Debt | 67.5B | 63.7B | 77.9B |
ABBV | PFE | UNH | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 34 | 88 | 82 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 11 Undervalued | 5 Undervalued | 5 Undervalued | |
PROFIT vs RISK RATING 1..100 | 10 | 100 | 96 | |
SMR RATING 1..100 | 1 | 78 | 64 | |
PRICE GROWTH RATING 1..100 | 48 | 53 | 16 | |
P/E GROWTH RATING 1..100 | 22 | 33 | 7 | |
SEASONALITY SCORE 1..100 | 5 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PFE's Valuation (5) in the Pharmaceuticals Major industry is in the same range as UNH (5) in the Managed Health Care industry, and is in the same range as ABBV (11) in the Pharmaceuticals Major industry. This means that PFE's stock grew similarly to UNH’s and similarly to ABBV’s over the last 12 months.
ABBV's Profit vs Risk Rating (10) in the Pharmaceuticals Major industry is significantly better than the same rating for UNH (96) in the Managed Health Care industry, and is significantly better than the same rating for PFE (100) in the Pharmaceuticals Major industry. This means that ABBV's stock grew significantly faster than UNH’s and significantly faster than PFE’s over the last 12 months.
ABBV's SMR Rating (1) in the Pharmaceuticals Major industry is somewhat better than the same rating for UNH (64) in the Managed Health Care industry, and is significantly better than the same rating for PFE (78) in the Pharmaceuticals Major industry. This means that ABBV's stock grew somewhat faster than UNH’s and significantly faster than PFE’s over the last 12 months.
UNH's Price Growth Rating (16) in the Managed Health Care industry is in the same range as ABBV (48) in the Pharmaceuticals Major industry, and is somewhat better than the same rating for PFE (53) in the Pharmaceuticals Major industry. This means that UNH's stock grew similarly to ABBV’s and somewhat faster than PFE’s over the last 12 months.
UNH's P/E Growth Rating (7) in the Managed Health Care industry is in the same range as ABBV (22) in the Pharmaceuticals Major industry, and is in the same range as PFE (33) in the Pharmaceuticals Major industry. This means that UNH's stock grew similarly to ABBV’s and similarly to PFE’s over the last 12 months.
| ABBV | PFE | UNH | |
|---|---|---|---|
| RSI ODDS (%) | 2 days ago 26% | N/A | 2 days ago 53% |
| Stochastic ODDS (%) | 2 days ago 45% | 2 days ago 65% | 2 days ago 65% |
| Momentum ODDS (%) | 2 days ago 67% | 2 days ago 56% | 2 days ago 56% |
| MACD ODDS (%) | 5 days ago 60% | 2 days ago 49% | 2 days ago 59% |
| TrendWeek ODDS (%) | 2 days ago 59% | 2 days ago 58% | 2 days ago 54% |
| TrendMonth ODDS (%) | 2 days ago 61% | 2 days ago 50% | 2 days ago 50% |
| Advances ODDS (%) | 2 days ago 57% | 2 days ago 56% | 2 days ago 54% |
| Declines ODDS (%) | 6 days ago 48% | 4 days ago 58% | 4 days ago 54% |
| BollingerBands ODDS (%) | 2 days ago 42% | 2 days ago 59% | 2 days ago 62% |
| Aroon ODDS (%) | 2 days ago 65% | 2 days ago 59% | 2 days ago 42% |
Advertisement
ABBV and
Correlation & Price change
A.I.dvisor indicates that over the last year, ABBV has been loosely correlated with PFE. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ABBV jumps, then PFE could also see price increases.
| Ticker / NAME | Correlation To ABBV | 1D Price Change % | ||
|---|---|---|---|---|
| ABBV | 100% | +1.02% | ||
| PFE - ABBV | 57% Loosely correlated | +1.36% | ||
| BMY - ABBV | 52% Loosely correlated | +1.18% | ||
| NVS - ABBV | 47% Loosely correlated | +0.51% | ||
| MRK - ABBV | 46% Loosely correlated | +0.44% | ||
| AMGN - ABBV | 46% Loosely correlated | +1.15% | ||
More | ||||
PFE and
Correlation & Price change
A.I.dvisor indicates that over the last year, PFE has been loosely correlated with MRK. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if PFE jumps, then MRK could also see price increases.
| Ticker / NAME | Correlation To PFE | 1D Price Change % | ||
|---|---|---|---|---|
| PFE | 100% | +1.36% | ||
| MRK - PFE | 66% Loosely correlated | +0.44% | ||
| BMY - PFE | 59% Loosely correlated | +1.18% | ||
| AMGN - PFE | 52% Loosely correlated | +1.15% | ||
| NVS - PFE | 51% Loosely correlated | +0.51% | ||
| BIIB - PFE | 51% Loosely correlated | -0.57% | ||
More | ||||
UNH and
Correlation & Price change
A.I.dvisor indicates that over the last year, UNH has been loosely correlated with ELV. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if UNH jumps, then ELV could also see price increases.